44
Views
2
CrossRef citations to date
0
Altmetric
Review

Risk factors of floppy iris syndrome: current insights

, , &
Pages 125-132 | Received 15 Nov 2020, Accepted 14 Jan 2021, Published online: 31 Jan 2021

References

  • Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005;31:664–673.
  • Chang DF, Campbell JR, Colin J, et al. Prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin. Ophthalmology. 2014;121:829–834.
  • Cheung CMGG, Awan MA, Peh KK, et al. Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist. Am J Ophthalmol. 2007;143:150–151.
  • Wahl M, Tipotsch-Maca SM, Vecsei-Marlovits PV. Intraoperative floppy iris syndrome and its association with various concurrent medications, bulbus length, patient age and gender. Graefe’s Arch Clin Exp Ophthalmol. 2017;255:113–118.
  • Chatziralli IP, Peponis V, Parikakis E, et al. Risk factors for intraoperative floppy iris syndrome: A prospective study. Eye. 2016;30:1039–1044.
  • Issa SA, Dagres E. Intraoperative floppy-iris syndrome and finasteride intake. J Cataract Refract Surg. 2007;33:2142–2143.
  • Kaczmarek IA, Prost ME, Wasyluk J. Clinical risk factors associated with intraoperative floppy iris syndrome: a prospective study. Int Ophthalmol [Internet]. 2019;39:541–549.
  • Tzamalis A, Malyugin B, Ziakas N, et al. Angiotensin receptor inhibitors as main predisposing factor for intraoperative floppy iris syndrome in women. J Cataract Refract Surg. 2019;45:696–697.
  • Tzamalis A, Matsou A, Dermenoudi M, et al. The role of sex in intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2019;45:41–47.
  • Chen AA, Kelly JP, Bhandari A, et al. Pharmacologic prophylaxis and risk factors for intraoperative floppy-iris syndrome in phacoemulsification performed by resident physicians. J Cataract Refract Surg. 2010;36:898–905.
  • Lunacek A, Mohamad Al-Ali B, Radmayr C, et al. Ten years of intraoperative floppy iris syndrome in the era of α-blockers. Cent Eur J Urol. 2018;71:98–104.
  • Schwinn DA, Michelotti GA. alpha1-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha1d subtype in filling symptoms and effects of ageing on vascular expression. BJU Int. 2000;85(Suppl 2):6–11.
  • Goseki T, Ishikawa H, Ogasawara S, et al. Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: possible mechanism of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2012;38:1643–1649.
  • Nuzzi R, Arnoffi P, Tridico F. Best prophylactic strategy in groups at risk of intraoperative floppy Iris syndrome development: comparison between atropine instillation and adrenaline intracameral injection. Open Ophthalmol J. 2018;12:34–40.
  • Santaella RM, Destafeno JJ, Stinnett SS, et al. The effect of alpha1-adrenergic receptor antagonist tamsulosin (Flomax) on iris dilator smooth muscle anatomy. Ophthalmology. 2010 Sep;117(9):1743–1749.
  • Muqit MMK, Menage MJ. Intraoperative floppy iris syndrome. Ophthalmology. United States. 2006;113:1885–1886. author reply 1886.
  • Lim L-A, Frost A. Iris tears secondary to intraoperative floppy-iris syndrome associated with tamsulosin. J Cataract Refract Surg. United States. 2006;32:1777.
  • Neff KD, Sandoval HP, Fernández de Castro LE, et al. Factors associated with intraoperative floppy Iris syndrome. Ophthalmology. 2009;116:658–663.
  • Takayanagi I. Effects of aging on drug receptor mechanisms in smooth muscles. Nihon Yakurigaku Zasshi. 1994;104:163–175.
  • Satoh K, Takaku Y, Ohtsuki K, et al. Effects of aging on fluorescein leakage in the iris and angle in normal subjects. Jpn J Ophthalmol. 1999;43:166–170.
  • Panagis L, Basile M, Friedman AH, et al. Intraoperative floppy iris syndrome: report of a case and histopathologic analysis. Arch Ophthalmol (Chicago, Ill 1960). 2010;128:1437–1441.
  • Schwinn DA, Afshari NA. alpha(1)-Adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome. Surv Ophthalmol. 2006;51:501–512.
  • Altan-Yaycioglu R, Gedik S, Pelit A, et al. Clinical factors associated with floppy iris signs: A prospective study from two centers. Ophthalmic Surg Lasers Imaging. 2009;40:232–238.
  • Mylona I, Dermenoudi M, Ziakas N, et al. Increased pupil diameter is a protective factor against intraoperative floppy-iris syndrome. Clin Exp Optom. 2019;103:1–2.
  • Casuccio A, Cillino G, Pavone C, et al. Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2011;37:1447–1454.
  • Terauchi Y, Horiguchi H, Shiba T. The pharmacological mydriatic pupil-to-limbal diameter ratio as an intuitive predictor for the risk of intraoperative floppy iris syndrome. J Ophthalmol. 2018;2018:1–8.
  • Blake CR, Lai WW, Edward DP. Racial and ethnic differences in ocular anatomy. Int Ophthalmol Clin. 2003;43:9–25.
  • Alio JL. Cataract surgery: from today’s standards to future progress. Asia-Pacific J Ophthalmol. (Philadelphia, Pa). China. 2017;6(4):309.
  • Schwinn DA, Roehrborn CG. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol Off J Jpn Urol Assoc. 2008;15:193–199.
  • Keklikci U, Isen K, Unlu K, et al. Incidence, clinical findings and management of intraoperative floppy iris syndrome associated with tamsulosin. Acta Ophthalmol. 2009;87:306–309.
  • González Martín-Moro J, Muñoz Negrete F, Lozano Escobar I, et al. Intraoperative floppy-iris syndrome. Arch Soc Esp Oftalmol. 2013;88:64–76.
  • Oshika T, Ohashi Y, Inamura M, et al. Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist. Am J Ophthalmol. 2007;143:150–151.
  • Shah N, Tendulkar M, Brown R. Should we anticipate intraoperative floppy iris syndrome (IFIS) even with very short history of tamsulosin? Eye (Lond). 2009;23(3):740.
  • Nguyen DQ, Sebastian RT, Kyle G. Surgeon’s experiences of the intraoperative floppy iris syndrome in the United Kingdom. Eye (Lond). 2007;21(3):443–444.
  • Yaycioglu O, Altan-Yaycioglu R. Intraoperative floppy iris syndrome: facts for the urologist. Urology. 2010;76:272–276.
  • Wilde MI, Fitton A, Sorkin EM. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs Aging. 1993;3:258–277.
  • Fulton B, Wagstaff AJ, Sorkin EM. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs. 1995;49:295–320.
  • Wilde MI, Fitton A, McTavish D. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs. 1993;45:410–429.
  • Dogan M, Kutluksaman B, Keles I, et al. The effects of systemic alfuzosin and tamsulosin hydrochloride on choroidal thickness and pupil diameter sizes in cases with benign prostatic hyperplasia. Curr Eye Res. 2017;42:1638–1643.
  • Ipekci T, Akin Y, Hoscan B, et al. Intraoperative floppy iris syndrome associated with silodosin. Acta Ophthalmol. 2015;93(4):e306.
  • Chatterjee S, Agrawal D. Silodosin-associated intraoperative floppy iris syndrome. Indian J Ophthalmol. 2017;65(6):538–539.
  • Ozcura F, Irgat SG. Bilateral Intraoperative Floppy Iris Syndrome Associated with Silodosin Intake. Eurasian J Med. 2020;52:100–102.
  • Wong AC-M, Mak ST. Finasteride-associated cataract and intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2011;37:1351–1354.
  • Papadopoulos R, Bachariou A. Intraoperative floppy-iris syndrome associated with chronic intake of donepezil. J Cataract Refract Surg. 2007;33(11):1997–1998.
  • González-Martín-Moro J, González-López JJ, Zarallo-Gallardo J, et al. Intraoperative floppy iris syndrome after treatment with duloxetine: coincidence, association, or causality? Arch Soc Esp Oftalmol. 2015;90:94–96.
  • Ugarte M, Leong T, Rassam S, et al. Intraoperative floppy-iris syndrome, alpha1-adrenergic antagonists, and chronic intake of mianserin: is there an association? J Cataract Refract Surg. 2007;33(1):170.
  • Chatziralli IP, Sergentanis TN. Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology. 2011;118:730–735.
  • Bilgin B, Ilhan D, Çetinkaya A, et al. Intraoperative floppy iris syndrome associated with quetiapine. Eye (Lond). 2013;27(5):673.
  • Pringle E, Packard R. Antipsychotic agent as an etiologic agent of IFIS. J Cataract Refract Surg. 2005;31(12):2240–1. author reply 2241.
  • Unal M, Yücel I, Tenlik A. Intraoperative floppy-iris syndrome associated with chronic use of chlorpromazine. Eye (Lond). 2007;21(9):1241–1242.
  • Matsuo M, Sano I, Ikeda Y, et al. Intraoperative floppy-iris syndrome associated with use of antipsychotic drugs. Can J Ophthalmol. 2016;51:294–296.
  • Ford RL, Sallam A, Towler HMA. Intraoperative floppy iris syndrome associated with risperidone intake. Eur J Ophthalmol. 2011;21:210–211.
  • El-Ghatit AM. Association of IFIS and vasodepressor medication. J Cataract Refract Surg. 2006;32(4):546–547.
  • Herd MK. Intraoperative floppy-iris syndrome with doxazosin. J Cataract Refract Surg. 2007;33(4):562.
  • Dhingra N, Rajkumar KN, Kumar V. Intraoperative floppy iris syndrome with doxazosin. Eye (Lond). 2007;21(5):678–679.
  • Calotti F, Steen D. Labetalol causing intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007;33(1):170–171.
  • Ozer PA, Altiparmak UE, Unlu N, et al. Intraoperative floppy-iris syndrome: comparison of tamsulosin and drugs other than alpha antagonists. Curr Eye Res. 2013;38:480–486.
  • Bertsimas D, Dunn J. Optimal classification trees. Mach Learn Mach Learn. 2017;106:1039–1082.
  • Esen F, Bulut AE, Toker E. Efficacy and safety of low-concentration, bisulphite-containing, intracameral epinephrine and topical atropine treatments for the prevention of intraoperative floppy iris syndrome. Cutan Ocul Toxicol. 2018;37:286–290.
  • Bendel RE, Phillips MB. Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin. J Cataract Refract Surg. 2006;32:1603–1605.
  • Visco D. Effect of phenylephrine/ketorolac on iris fixation ring use and surgical times in patients at risk of intraoperative miosis. Clin Ophthalmol. 2018;12:301–305.
  • Blau-Most M, Mimouni M, Geffen N, et al. Modified corneal incisions for cataract surgery in patients treated with tamsulosin: a prospective study. Curr Eye Res. 2019;44:381–384.
  • Bucci FAJ, Michalek B, Fluet AT. Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgery. Clin Ophthalmol. 2017;11:1039–1043.
  • Chang DF, Osher RH, Wang L, et al. Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology. 2007;114:957–964.
  • Enright JM, Karacal H, Tsai LM. Floppy iris syndrome and cataract surgery. Curr Opin Ophthalmol. 2017;28:29–34.
  • Gurbaxani A, Packard R. Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye (Lond). 2007;21:331–332.
  • Shugar JK. Use of epinephrine for IFIS prophylaxis. J Cataract Refract Surg. 2006;32(7):1074–1075.
  • Guthrie S, Jensen T, Hartley RC, et al. Assessing the accuracy of intracameral phenylephrine preparation in cataract surgery. Eye (Lond). 2018;32:1615–1620.
  • Silverstein SM, Rana VK, Stephens R, et al. Effect of phenylephrine 1.0%-ketorolac 0.3% injection on tamsulosin-associated intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2018;44:1103–1108.
  • Donnenfeld ED, Whitaker JS, Jackson MA, et al. Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery. J Cataract Refract Surg. 2017;43:597–605.
  • Arshinoff SA. Modified SST-USST for tamsulosin-associated intraoperative [corrected] floppy-iris syndrome. J Cataract Refract Surg. 2006;32:559–561.
  • Klysik A, Korzycka D. Sub-Tenon injection of 2% lidocaine prevents intra-operative floppy iris syndrome (IFIS) in male patients taking oral α-adrenergic antagonists. Acta Ophthalmol. 2014;92:535–540.
  • Huynh ML, Sanders R, Sallam AB. Modified hydrodissection to prevent intraoperative iris prolapse. J Cataract Refract Surg. 2020;46(12):1680–1681.
  • Tint NL, Dhillon AS, Alexander P. Management of intraoperative iris prolapse: stepwise practical approach. J Cataract Refract Surg. 2012;38:1845–1852.
  • Ten Tips to Prevent and Treat Iris Prolapse [Internet]. [ cited 2020 Oct 31]. Available from: https://webeye.ophth.uiowa.edu/eyeforum/tutorials/Ten-Tips-Iris-Prolapse.htm
  • Managing Mild Iris Prolapse during Phaco – cataract Coach [Internet]. [ cited 2020 Oct 31]. Available from: https://cataractcoach.com/2018/10/05/managing-mild-iris-prolapse-during-phaco/
  • Iris prolapse treatment & management: medical care, surgical care, consultations [Internet]. [ cited 2020 Oct 31]. Available from: https://emedicine.medscape.com/article/1209310-treatment
  • Campbell RJ, El-Defrawy SR, Gill SS, et al. Evolution in the risk of cataract surgical complications among patients exposed to tamsulosin: a population-based study. Ophthalmology. 2019;126:490–496.
  • Doss EL, Potter MB, Chang DF. Awareness of intraoperative floppy-iris syndrome among primary care physicians. J Cataract Refract Surg. 2014;40(4):679–680.
  • IFIS associated with systemic alpha 1-antagonists [Internet]. [ cited 2020 Nov 1]. Available from: https://www.eyeworld.org/article-intraoperative-floppy-iris-syndrome–ifis–associated-with-systemic-alpha-1-antagonists

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.